Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1JOURNAL OF MEDICINAL CHEMISTRYIF6.82021-12-063PREAI
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1JOURNAL OF MEDICINAL CHEMISTRYIF6.82021-11-086PREAI
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2ACS MEDICINAL CHEMISTRY LETTERSIF42017-01-2428OAAI
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaACS MEDICINAL CHEMISTRY LETTERSIF42017-01-2350OAAI
Development of a Scalable Synthesis of an Azaindolyl-Pyrimidine Inhibitor of Influenza Virus ReplicationORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52016-04-2117PREAI
Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 InhibitorsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-10-0112OAAI
Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 SubunitANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-03-01174OAAI
Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2JOURNAL OF MEDICINAL CHEMISTRYIF6.82014-07-24208PREAI
Enthalpy of solvation correlations for organic solutes and gases dissolved in N,N-dimethylformamide and tert-butanolJOURNAL OF MOLECULAR LIQUIDSIF5.22009-01-0132PREAI
Enthalpy of solvation correlations for gaseous solutes dissolved in dibutyl ether and ethyl acetateTHERMOCHIMICA ACTAIF3.52008-04-0135PREAI
Enthalpy of solvation correlations for gaseous solutes dissolved in water and in 1-octanol based on the abraham modelJOURNAL OF CHEMICAL INFORMATION AND MODELINGIF5.32006-12-15113OA
Pyrazolones as therapeutics for kinase-mediated inflammatory disordersEXPERT OPINION ON THERAPEUTIC PATENTSIF4.62005-10-289PREAI
Samarium barbier reactions of α-iodomethyloxazoles and thiazoles with aliphatic aldehydesORGANIC LETTERSIF52005-08-1819PREAI
Studies of stereocontrolled allylation reactions for the total synthesis of phorboxazole APROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12004-07-2648OAAI
Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-α productionJOURNAL OF MEDICINAL CHEMISTRYIF6.82004-04-24146PREAI
Synthetic studies toward phorboxazole A.: Stereoselective synthesis of the C28-C46 side chain fragmentORGANIC LETTERSIF52000-08-3042PREAI